AMREP Corp. (AXR) stock analysis
Close on Nov 12, 2026Market cap $112.46MP/E 19.6Yield –
StockData Score
Prices as of Nov 12, 2026How the score works
Mixed10 of 30 checks passed
Amrep passes 10 of the 30 checks behind our score; 8 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 2/6
- Growth
- 0/6
- Past performance
- 3/6
- Financial health
- 5/6
- Dividend
- 0/6
What stands out
No debt
Amrep has no borrowings on its latest balance sheet.
Earnings grew over 5 years
Net income grew 6.8% a year on average over the last five fiscal years.
Interest well covered
No meaningful interest expense to cover.
Debt covered by cash flow
There is no debt to cover.
What to watch
Margin of safety under 20%
The price is 0.9% above fair value, so there is no margin of safety.
Trading above fair value
The share price of $21.12 is above our fair value estimate of $20.92.
Return on equity under 15%
Return on equity was 4.3% over the last twelve months and averaged 12.9% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 5.1%, below the 10% that usually covers the cost of capital.
Valuation2/6
P/E above its 5-year median
Amrep's P/E of 19.6 is above its own 5-year median of 11.7.
P/E below the industry
Amrep's P/E of 19.6 is below the Real Estate median of 23.4.
EV/EBITDA above its 5-year median
Amrep's EV/EBITDA of 10.5 is above its 5-year median of 6.3.
P/B below the industry
Amrep's price-to-book of 0.80 is below the Real Estate median of 0.97.
Trading above fair value
The share price of $21.12 is above our fair value estimate of $20.92.
Margin of safety under 20%
The price is 0.9% above fair value, so there is no margin of safety.
Growth0/6
Revenue growing under 10% a year
Revenue grew 2.8% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -22.5% a year over the last three fiscal years.
Earnings growth not accelerating
Net income grew -56.0% over the last twelve months, against a 5-year average of 6.8% a year.
Growing slower than the industry
Revenue grew -15.3% over the last twelve months; the Real Estate median is 5.4%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin trend
This company does not report gross profit.
Past performance3/6
Return on equity under 15%
Return on equity was 4.3% over the last twelve months and averaged 12.9% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 5.1%, below the 10% that usually covers the cost of capital.
Return on equity above the industry
Amrep's return on equity of 4.3% is above the Real Estate median of 0.1%.
Earnings grew over 5 years
Net income grew 6.8% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 14.3% over the last twelve months, against a 5-year average of 26.0%.
Net margin above the industry
Amrep's net margin of 14.3% is above the Real Estate median of 0.8%.
Financial health5/6
No debt
Amrep has no borrowings on its latest balance sheet.
Debt not rising
With no debt today, leverage cannot have risen.
Debt covered by cash flow
There is no debt to cover.
Interest well covered
No meaningful interest expense to cover.
Short-term liquidity
The balance sheet is not split into current and non-current items.
Low bankruptcy risk
The Altman Z-score is 16.29; above 3 is the safe zone and below 1.8 the distress zone.
Dividend0/6
No dividend
Amrep has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itOur estimate per share
$20.92
The share price is 1% above this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 18.7× | 11.7× | 23.4× | $20.18 | 40% |
| EV/EBITDA | 7.7× | 6.3× | 8.7× | $17.99 | 35% |
| P/B | 0.9× | 0.9× | 1.0× | $24.51 | 10% |
| Earnings power | 7.5% cost of equity | – | – | $27.36 | 15% |
| Fair value | $20.92 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 11.7
- Real Estate median 23.4
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
High risk
- Average value traded per day
- $134.57K
- Value traded per 1% price move
- $96.43K
Downside
Low risk
- Typical loss in a bad month
- 13.5%
- Volatility (annualized)
- 41%
- Sharpe ratio, 1 year
- -0.21
- Beta to the S&P 500 (5Y)
- 0.46
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2012 to 2026
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2026
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +6.3% | +2.8% | +5.7% | +2.4% | |
| Operating income | +2.4% | +28.6% | +6.5% | – | |
| Net income | -19.1% | -22.1% | +6.8% | – | |
| EPS, diluted | -19.4% | -22.5% | +15.0% | – | |
| Free cash flow | +32.3% | +26.9% | +0.3% | +17.0% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2017 | FY2021 | FY2026 | Trend |
|---|---|---|---|---|
| Return on equity | -0.0% | 8.5% | 7.6% | |
| Return on assets | -0.0% | 7.6% | 7.4% | |
| Capex to revenue | 0.6% | 0.0% | 0.2% | |
| Diluted shares | 8M | 0M | 5M |
Where the cash went
Fiscal 2022 to 2026, five years combined
Amrep generated $55.70M from operations and spent $24.46M on capital expenditure, dividends and share buybacks. 10% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2026 | 19.5% | 0.38× | 1.03× | 7.6% |
| FY2025 | 25.6% | 0.39× | 1.03× | 10.3% |
| FY2024 | 13.0% | 0.43× | 1.04× | 5.8% |
| FY2023 | 44.8% | 0.46× | 1.09× | 22.4% |
| FY2022 | 26.9% | 0.61× | 1.12× | 18.4% |
| FY2021 | 18.4% | 0.41× | 1.12× | 8.5% |
| FY2020 | -31.4% | 0.19× | 1.13× | -6.8% |
| FY2019 | 12.0% | 0.12× | 1.17× | 1.7% |
| FY2018 | 2.7% | 0.08× | 1.23× | 0.3% |
| FY2017 | -0.0% | 0.37× | 1.35× | -0.0% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2026 against fiscal 2025
- ProfitableNet income above zero$10.29M
- Cash generatingOperating cash flow above zero$12.88M
- Return on assets improvedROA up on the prior year10.4% → 7.7%
- Earnings backed by cashOperating cash flow above net income$12.88M vs $10.29M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise5M → 5M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.40 → 0.40
See a number that looks wrong?